Crescita Therpeutc (TSE:CTX) has released an update.
Crescita Therapeutics has successfully concluded its Annual General and Special Meeting, with overwhelming shareholder support for the election of its director nominees and the reappointment of Ernst & Young LLP as external auditors. Shareholders also approved the continuation of the company’s Share Incentive Plan, endorsing the current strategic direction of the Canadian commercial dermatology firm.
For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.
